Fig. 2: KLHL17 is associated with poor prognosis of patients with non-small cell lung cancer. | Laboratory Investigation

Fig. 2: KLHL17 is associated with poor prognosis of patients with non-small cell lung cancer.

From: Upregulation of KLHL17 promotes the proliferation and migration of non-small cell lung cancer by activating the Ras/MAPK signaling pathway

Fig. 2: KLHL17 is associated with poor prognosis of patients with non-small cell lung cancer.

A Representative immunohistochemistry images of KLHL17 staining in normal bronchial epithelium (a), normal alveolar epithelium (b), highly differentiated lung squamous cell carcinoma (c), highly differentiated lung adenocarcinoma(d), poorly differentiated lung squamous cell carcinoma(e), and poorly differentiated lung adenocarcinoma (f). B Western blotting analysis of KLHL17 expression in eight paired non-small cell lung cancer tissues and their corresponding adjacent normal tissues. *P < 0.05 vs corresponding adjacent normal tissues. C Kaplan–Meier plotter analysis showing the correlation between KLHL17 expression and the prognosis of patients with lung cancer. Red line: high KLHL17 expression; black line: low KLHL17 expression (P = 8.8e−05). Data were from the Kaplan–Meier plotter database (https://kmplot.com/analysis/index.php?p=service&cancer=lung).

Back to article page